https://aimarketreport.com/ Logo

Point of Care Diagnostics Market

Point of Care Diagnostics Market Size, Share & Trends Analysis Report

Point of Care Diagnostics Market Size, Share & Trend Analysis 2029

Published
Report ID : AIMR 1281
Number of pages : 200
Published Date : May 2023
Category : Life Sciences
Delivery Timeline : 48 hrs

Point of Care Diagnostics Market: Overview and Market Size

Point of care (POC) diagnostics refers to medical tests that can be performed at or near the site of patient care, such as in a hospital, doctor's office, or even in a patient's home. POC diagnostics can include blood glucose monitoring, pregnancy testing, and infectious disease testing, among others.

The global POC diagnostics market is expected to grow from ~$38.1 billion in 2027, at a compound annual growth rate (CAGR) of +6% during the forecast period.

Key Players-

  • F. Hoffmann-La Roche Ltd.

  • Danaher

  • BD

  • Qiagen

  • Abbott

  • Siemens Healthcare AG

  • bioMerieux SA

  • Zoetis, Inc.

  • Instrumentation Laboratory

  • Nova Biomedical

  • Quidel Corp.

  • Trividia Health, Inc.

  • Sekisui Diagnostics

  • Nipro Corp.

  • Trinity Biotech

  • Orasure Technologies, Inc.

  • Spectral Medical, Inc. 

Segmentation-

BY PRODUCT

  • Glucose Monitoring Kits
  • Infectious Diseases Testing Kits
  • Pregnancy And Fertility Testing Kits
  • Hematology Testing Kits
  • Cardiometabolic Monitoring Kits
  • Urinalysis Testing Kits
  • Cholesterol Test Strips
  • Others
  • Drugs Abuse Testing Kits

BY MODE OF PRESCRIPTION

  • Prescription Based Devices
  • Otc Based Devices

BY END USER

  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care
  • Others

Major Trends and Drivers Affecting the Point of Care Diagnostics Market-

One major trend in the POC diagnostics market is the increasing demand for rapid and accurate diagnostic tests, particularly for infectious diseases such as COVID-19. The COVID-19 pandemic has highlighted the importance of POC diagnostics in quickly identifying and treating infected patients. Another trend is the development of more sophisticated POC diagnostic tests that can detect multiple diseases or biomarkers in a single test.

The increasing prevalence of chronic diseases such as diabetes and cancer is also driving the growth of the POC diagnostics market. POC diagnostic tests can help patients monitor their conditions more closely and make more informed decisions about their health.

Opportunities and Threats in the Point of Care Diagnostics Market-

One major opportunity in the POC diagnostics market is the potential for new diagnostic tests to address unmet medical needs. For example, there is a growing demand for POC tests that can quickly diagnose sepsis, a potentially life-threatening condition that can be difficult to detect.

However, there are also several threats to the POC diagnostics market. One threat is the potential for inaccurate or unreliable POC diagnostic tests, which can lead to misdiagnosis and inappropriate treatment. Another threat is the competition from alternative diagnostic technologies, such as laboratory-based tests or molecular diagnostics.

Regulatory and Legal Issues Affecting the Point of Care Diagnostics Market-

Regulatory and legal issues are a major concern for companies operating in the POC diagnostics market. Companies must comply with strict regulations regarding the safety and efficacy of their diagnostic tests, and must obtain regulatory approval before marketing their products.

In addition, there are concerns about the reimbursement policies for POC diagnostic tests. Some insurance providers may not cover the cost of certain POC tests, which can limit patient access to these important diagnostic tools.

Target Demographics and Pricing Trends in the Point of Care Diagnostics Market-

The target demographics for the POC diagnostics market vary depending on the type of diagnostic test. For example, blood glucose monitoring is primarily used by patients with diabetes, while infectious disease testing may be used by a wider range of patients.

Pricing trends in the POC diagnostics market also vary depending on the type of test and the target demographic. Some POC tests, such as blood glucose monitors, are relatively inexpensive and widely available, while others, such as molecular diagnostic tests, can be more expensive and require specialized equipment.

Conclusion-

Overall, the global POC diagnostics market is expected to continue to grow in the coming years, driven by factors such as increasing demand for rapid and accurate diagnostic tests, the growing prevalence of chronic diseases, and the development of more sophisticated POC diagnostic tests.

SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments

BY PRODUCT

  • Glucose Monitoring Kits
  • Infectious Diseases Testing Kits
  • Pregnancy And Fertility Testing Kits
  • Hematology Testing Kits
  • Cardiometabolic Monitoring Kits
  • Urinalysis Testing Kits
  • Cholesterol Test Strips
  • Others
  • Drugs Abuse Testing Kits

BY MODE OF PRESCRIPTION

  • Prescription Based Devices
  • Otc Based Devices

BY END USER

  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care
  • Others
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • F. Hoffmann-La Roche Ltd.

  • Danaher

  • BD

  • Qiagen

  • Abbott

  • Siemens Healthcare AG

  • bioMerieux SA

  • Zoetis, Inc.

  • Instrumentation Laboratory

  • Nova Biomedical

  • Quidel Corp.

  • Trividia Health, Inc.

  • Sekisui Diagnostics

  • Nipro Corp.

  • Trinity Biotech

  • Orasure Technologies, Inc.

  • Spectral Medical, Inc. 

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

AI® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2025-26 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market

PaymentModes